CNR Institutional Research Information System

DI MARZO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.469
NA - Nord America 3.270
SA - Sud America 3.010
EU - Europa 1.341
AF - Africa 258
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 21.367
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.981
US - Stati Uniti d'America 3.041
CN - Cina 2.648
BR - Brasile 2.486
HK - Hong Kong 1.875
VN - Vietnam 1.195
KR - Corea 679
IT - Italia 399
IN - India 228
NL - Olanda 195
AR - Argentina 194
FI - Finlandia 142
GB - Regno Unito 137
JP - Giappone 126
BD - Bangladesh 116
IL - Israele 100
EC - Ecuador 96
DE - Germania 93
MX - Messico 93
ID - Indonesia 92
ZA - Sudafrica 79
IQ - Iraq 62
CA - Canada 60
TR - Turchia 58
CO - Colombia 53
PK - Pakistan 53
SA - Arabia Saudita 52
UA - Ucraina 50
FR - Francia 42
RU - Federazione Russa 42
VE - Venezuela 42
MA - Marocco 40
PY - Paraguay 38
ES - Italia 36
AT - Austria 35
PE - Perù 35
UZ - Uzbekistan 34
CL - Cile 32
EG - Egitto 31
PL - Polonia 28
KE - Kenya 23
TN - Tunisia 23
UY - Uruguay 23
PH - Filippine 19
AZ - Azerbaigian 17
DZ - Algeria 16
SE - Svezia 16
JO - Giordania 15
TT - Trinidad e Tobago 14
BG - Bulgaria 13
IE - Irlanda 13
JM - Giamaica 13
MY - Malesia 11
NP - Nepal 11
DO - Repubblica Dominicana 10
AU - Australia 9
HU - Ungheria 9
TH - Thailandia 9
AE - Emirati Arabi Uniti 8
KZ - Kazakistan 8
LB - Libano 8
SN - Senegal 8
AL - Albania 7
BE - Belgio 7
BH - Bahrain 7
BO - Bolivia 7
CZ - Repubblica Ceca 7
OM - Oman 7
PT - Portogallo 7
RO - Romania 7
RS - Serbia 7
TW - Taiwan 7
BY - Bielorussia 6
CR - Costa Rica 6
DK - Danimarca 6
EE - Estonia 6
BA - Bosnia-Erzegovina 5
ET - Etiopia 5
GA - Gabon 5
GE - Georgia 5
HN - Honduras 5
KG - Kirghizistan 5
LT - Lituania 5
NG - Nigeria 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
GT - Guatemala 4
KH - Cambogia 4
PA - Panama 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
GF - Guiana Francese 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MD - Moldavia 3
Totale 21.311
Salva come PNG Salva come JPEG
Città #
Singapore 3.856
Hong Kong 1.869
Hefei 1.604
Santa Clara 1.166
Seoul 666
Ho Chi Minh City 449
Beijing 444
Hanoi 261
Ashburn 212
San Jose 199
Dallas 171
São Paulo 165
Los Angeles 98
Minamishinagawa 92
Helsinki 83
Rio de Janeiro 82
Naples 74
Brasília 59
Da Nang 59
Bengaluru 56
Haiphong 50
Lappeenranta 48
Buffalo 47
Belo Horizonte 44
Curitiba 43
New York 43
Dhaka 39
Rome 38
Campinas 34
Guarulhos 34
Biên Hòa 33
Porto Alegre 32
Quito 32
Tashkent 31
Phoenix 30
Afragola 28
Johannesburg 27
Salvador 27
Baghdad 24
Nuremberg 23
Asunción 22
Guayaquil 22
Tokyo 22
Warsaw 22
Casandrino 21
Guangzhou 21
Lima 21
Milan 21
Osasco 21
London 20
Thái Bình 20
Mexico City 19
Nairobi 19
Ribeirão Preto 19
Buenos Aires 18
Cairo 18
Fortaleza 18
Goiânia 18
Houston 18
Hải Dương 18
Quận Bình Thạnh 18
Brooklyn 17
Cape Town 17
Montevideo 17
Santo André 17
Uberlândia 17
Frankfurt am Main 16
Jakarta 16
Jeddah 16
Sorocaba 16
Thái Nguyên 16
Bắc Giang 15
Bắc Ninh 15
Caxias do Sul 15
Istanbul 15
Vienna 15
Amman 14
Riyadh 14
Stockholm 14
São José dos Campos 14
Viamão 14
Betim 13
Chennai 13
Chicago 13
Dammam 13
Lahore 13
Montes Claros 13
São Bernardo do Campo 13
São José do Rio Preto 13
The Dalles 13
Atlanta 12
Baku 12
Mumbai 12
Ninh Bình 12
Recife 12
Dublin 11
Juiz de Fora 11
Kolkata 11
Manaus 11
New Delhi 11
Totale 13.330
Salva come PNG Salva come JPEG
Nome #
First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury 90
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. 85
Short and efficient synthesis of alkylresorcinols: a route for the preparation of cannabinoids 85
2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors 84
y The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil 78
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity 73
N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 72
Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice 70
Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice 70
Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis 69
Interactions of non-THC phytocannabinoids and Cannabis extracts with TRP channels and endocannabinoid metabolic enzymes 67
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists. 66
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington?s disease 66
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop 65
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. 65
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus. 64
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors 64
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson s disease 64
Synthesis of 18F-labeled nitrogen heterocyclic derivatives as new candidate for cannabinoid CB2 receptor PET imaging 64
The short-chain fatty acid acetate modulates orexin/hypocretin neurons: A novel mechanism in gut-brain axis regulation of energy homeostasis and feeding 64
Orexin-A Prevents Lipopolysaccharide-Induced Neuroinflammation at the Level of the Intestinal Barrier 63
Lipidic secondary metabolites as endogenous regulators or pharmacological tools in Hydrozoan development 63
Cannabinoids 61
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 61
Endocannabinoid chemical biology: a tool for the development of novel therapies 60
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. 60
A sustainable protocol for the synthesis of N-acyl tryptamines, a class of potential gut microbiota-derived endocannabinoid-like mediators 60
Anandamide: Endocannabinoid, endovanilloid, or both? 59
Pharmacological preparation for topical use containing npalmitoyl-vanillamide 59
Enantioselective synthesis of 1-(R)-hydroxypolygodial and its 9 Ñ epimer, 1-(R)-hydroxyisotadeonal 59
The cannabimimetic eicosanoid, anandamide, regulated rat brain protein kinase C and mouse macrophage arachidonate release 59
Biosynthesis of the novel endogenous 15-lipoxygenase metabolites N-13-hydroxy-octodecadienoyl-ethanolamine and 13-hydroxy-octodecadienoyl-glycerol by human neutrophils and Eosinophils 59
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 59
Endocannabinoid-based drugs with multiple sites of action: riding several horses against inflammation and hyper-reactivity 58
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 58
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity 58
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. 56
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity (vol 55, pg 1799, 2016) 56
CB1, but not CB2, mediates stimulation of bone formation induced by traumatic brain injury. 56
Olive oil-derived endocannabinoid-like mediators inhibit palatable food-induced reward and obesity 56
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 56
Oral Ultramicronized Palmitoylethanolamide:Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect 55
Enantiospecific synthesis of bioactive hydroxyeicosatetraenoic acids (HETEs) in Hydra magnipapillata. 54
Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes 54
Potential use of cannabimimetics in the treatment of cancer 54
Human gut microbiota and their production of endocannabinoid-like mediators are directly affected by a dietary oil 54
Pharmacological preparation for topical use containing n-palmitoyl-vanillamide 53
The gut microbiome, endocannabinoids and metabolic disorders. 53
Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors 53
Prostamide F2a receptor antagonists with inhibitory activity at FAAH: a way to prevent the confounding effects of pro-inflammatory mediators formed following selective FAAH inhibition? 53
Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain 53
Phytocannabinoids in the treatment of cancer 52
Cannabinoids and the expanded endocannabinoid system in neurological disorders 52
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy 52
Lipopolysaccharide-induced pulmonary inflammation is not accompanied by a release of anandamide into the lavage fluid or a down-regulation of the activity of fatty acid amide hydrolase 51
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis 50
Method for treating pain 1831Prov1 49
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo 49
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI 49
Nanoparticle-mediated cellular uptake-controlled release as a tool to study anandamide membrane transport 48
Anandamide receptors 48
Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease 48
The endocannabinoid system in principal forebrain neurons protects against excitotoxicity. 47
Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. 47
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1 47
Manipulation of dietary amino acids prevents and reverses obesity in mice through multiple mechanisms that modulate energy homeostasis 47
Altered endocannabinoid signalling after a high-fat diet in Apoe (-/-) mice:relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance 47
Early endocannabinoid-mediated depolarization-induced suppression of excitation delays the appearance of the epileptic phenotype in synapsin II knockout mice 47
'Endocannabinoids', endogenous phospholipid-derived metabolites with cannabimimetic properties: biosynthesis and catabolism 46
Anandamide and decidual remodelling: COX-2 oxidative metabolism as a key regulator 46
Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge eating disorder, but not in bulimia nervosa 46
Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis 46
In vitro and in vivo pharmacology of synthetic olivetol-derived cannabinoid receptor ligands. 45
Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol. 45
Why do cannabinoid receptors have more than one endogenous ligand? 45
Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100 ² up-regulation in vitro 45
Cannabinoid CB1 receptor activation inhibits MPTP-induced expression of S100B in glial cells thereby leading to survival of co-cultured neurons. Mechanism of action and involvement of endocannabinoids 45
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats 45
Tetrahydrolipstatin analogues: new selective pharmacological tools to investigate 2-AG metabolism 45
INSULIN AS A NEGATIVE REGULATOR OF PLASMA ENDOCANNABINOID LEVELS IN OBESE AND NONOBESE SUBJECTS 45
Indole-2-carboxamides as allosteric modulators of the cannabinoid CB1 receptor. 45
Mechanisms underlying in vivo neuroprotection by anandamide and the CB1/VR1 hybrid agonist arvanil 45
First separation of commendamide enantiomers 45
Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes 45
Oxidative metabolism of lipoamino acids and vanilloids by lipoxygenases and cyclooxygenases 44
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation 44
Acute Kappa opioid receptor blocking disrupts the pro-cognitive effect of cannabidiol in neuropathic rats 44
Life-long epigenetic programming of cortical architecture by maternal 'Western' diet during pregnancy 44
Beneficial effects of akkermansia muciniphila are not associated with major changes in the circulating endocannabinoidome but linked to higher mono-palmitoyl-glycerol levels as new pparα agonists 44
Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract 43
Orexin and endocannabinoid morphological interactions in the brain of adult zebrafish 43
Novel selective and metabolically stable inhibitors of anandamide cellular uptake 43
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia 43
In silico identification and experimental validation of (-)-muqubilin A, a marine norterpene peroxide, as PPARalpha/gamma-RXRalpha agonist and RARalpha positive allosteric modulator 43
Validation of a fast and sensitive UPLC-MS/MS quantitative method for N-acyl taurine analysis in biological samples 43
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 42
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects 42
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent. 42
Identification and characterization of cannabidiol as an ox1r antagonist by computational and in vitro functional validation 42
Protective Effects of N-Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury 42
Totale 5.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.556
article - articoli 63.511
book - libri 206
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.561
Totale 147.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024237 0 0 0 0 0 0 0 0 12 31 70 124
2024/20259.827 57 62 875 575 1.139 145 52 342 273 325 3.098 2.884
2025/202611.562 912 1.720 1.973 2.903 3.201 596 257 0 0 0 0 0
Totale 21.626